← Eichor
Study identifier: NCT06749639 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy

Condition: Inherited Retinal Diseases  ·  Sponsor: Peking Union Medical College Hospital

PhaseEARLY_Phase 1
Planned participants10
Who can joinAll sexes, 8 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E101 injection in subjects with RDH12 retinopathy.

This description comes directly from the study's public registry record.

Talk to the study team

Ruifang Sui, MD, PhD  ·  +8613511017280  ·  Hrfsui@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06749639